| Florence Fairbanks, APRN | |
|
5770 S 1500 W, Taylorsville, UT 84123-5216 | |
| (801) 265-3144 | |
| Not Available |
| Full Name | Florence Fairbanks |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 5770 S 1500 W, Taylorsville, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154348993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 2103544405 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Florence Fairbanks, APRN Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 265-3144 | Florence Fairbanks, APRN 5770 S 1500 W, Taylorsville, UT 84123-5216 Ph: (801) 265-3144 |
News Archive
A naturally occurring protein that blocks an inflammatory immune response was associated with better stroke recovery in a study conducted in mice, according to preliminary research to be presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2021.
Fragile X syndrome (FXS) is a genetic malady that is the most common inherited cause of autism and intellectual disability. Brain scientists know the gene defect that causes FXS, and the damage it does- misshaping the brain's synapses, the connections between neurons. But how that abnormal shaping of synapses translates to abnormal behavior is unclear.
Blackouts refer to partial or complete memory loss of events that occur while individuals are drinking. These individuals maintain consciousness during the event and may even be able to engage in complex behaviors such as conversing or driving.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, will be presenting new preclinical data in an animal model of Type 2 diabetes in which its anti-inflammatory therapeutic antibody candidate, XOMA 052, was used as monotherapy and in combination with the marketed anti-diabetic drugs exendin-4 (Byetta) or sitagliptin (Januvia).
Swedish researchers have developed COVseq, a SARS-CoV-2 genome tracker that can be produced at a large scale for a small cost.
› Verified 6 days ago
Mrs. Paige Jolynn Stodtmeister, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5770 S 1500 W, Taylorsville, UT 84123 Phone: 801-313-7711 | |
Janice Lamborn, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3845 W 4700 S, Taylorsville, UT 84118 Phone: 801-840-2101 | |
Samuel Harry Van Rensburg, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5770 S 1500 W, Taylorsville, UT 84123 Phone: 203-343-9490 | |
Lisa Ann Ostrander, AGNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1385 W 2200 S, Taylorsville, UT 84119 Phone: 801-944-0095 | |
Rachel Jenkins-lloyd, APRN, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1972 W 5400 S, Taylorsville, UT 84129 Phone: 801-598-7565 | |
Wendy Marie Rusin, A.P.R.N. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2907 W Midwest Dr, Taylorsville, UT 84129 Phone: 801-898-1754 |